Author

Michael S. Gordon

HonorHealthORCID 0000-0002-7679-9504Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexis Weston· 1 shared Erin KelleyiD· 1 shared Erkut Hasan BorazanciiD· 1 shared Frank Yung-Chin TsaiiD· 1 shared John A. AltiniD· 1 shared Jorge Soria‐BustosiD· 1 shared Justin Moser· 1 shared Mohan Rao KaadigeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexis Weston

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical Proof of Concept for a personalized SNAPTM-TIL (Specific Neo-Antigen Peptides -TIL) therapy platform

Tithi Ghosh, Erin Kelley, Jorge Soria‐Bustos, Trason G. Thode, Serina Ng, Taylor Bargenquast, Alexis Weston, Ryan Rodriguez del Villar, Mohan Rao Kaadige, Erkut Hasan Borazanci, Michael S. Gordon, Justin Moser, Frank Yung-Chin Tsai, Saul J. Priceman, Stephen J. Forman, , Sunil Sharma

This paper demonstrates a personalized SNAP-TIL therapy platform that improves TIL efficacy by enriching them with neoantigen-reactive T-cells, achieving high CD3+ cell content and significant tumor growth inhibition in preclinical models.

OncoImmunology · Jul 5, 2026Peer-reviewedImmunology